Upcoming Free Webinar – Parkinson’s Disease: Understanding and Helping to Improve Care – October 2 at Noon

By: Paul Tuite, MD, Professor, Neurology, University of Minnesota

Click here to register!

Handout – Parkinson’s Disease -Part 1

Handout – Parkinson’s Disease Part 2

Handout – Parkinson’s Disease Part 3

Earn 1 CEU, pre-approved for Social Workers by BOSW; self-submit other disciplines.
MGS is listed as a Continuing Education Resource by the MN Board of Nursing.
(The CEU is free for MGS members; $15 for non-members.)

Parkinson’s disease (PD) is a neurodegenerative disorder that affects about 15,000 Minnesotans. Due to the increase in the aging population, the numbers are expected to double by 2030.  The presence of loss of smell perception and/or the manifestation of REM behavioral sleep disorder are important clues that someone may have prodromal PD.

When someone has been diagnosed with PD, there is great interest in exploring the benefits of exercise as well as novel medications in the hope that this may provide a neuroprotective benefit.  With additional education persons with PD are being empowered to play a greater role in their own chronic disease management. The University of Minnesota, the only federally funded Morris K Udall Parkinson Center (udall.umn.edu) that is specifically focusing on deep brain stimulation, is piloting some of the best brain imaging in the world. While a cure is not yet available, research is being done to alter the course of disease as well as many are focused on providing the best care possible to those affected.

Objectives

Participants will be able to:

  • Understand prodromal Parkinson’s disease (PD)
  • Explain a symptomatic medication treatment strategy
  • Consider complementary therapies
  • Appreciate deep brain stimulation (DBS) for PD
  • Help the efforts to improve care for those with PD

Paul Tuite, MD, Professor, Neurology; University of Minnesota & MnDRIVE Neuromodulation Researcher

Since arriving at the University of Minnesota in 1996, Dr. Tuite has directed more than 35 clinical trials related to Parkinson’s disease (PD) and other movement disorders. In addition to evaluating new therapies, his interests include the development of novel brain MRI and nuclear imaging tests that may aid in the diagnosis of PD, increase our understanding of the disease, and monitor the effects of treatment. Dr. Tuite is also interested in rehabilitation and in developing methods to monitor and improve movements in people with PD.

References/Resources:

 

Reich and Savitt 2019 doi.org/10.1016/j.mcna.2018.10.014

Heinzel et al. Mov Dis 2019 doi.org/10.1002/mds.27802